116 related articles for article (PubMed ID: 20495311)
1. [Continuous administration and safety of S-1 in adjuvant chemotherapy for gastric cancer].
Kimura M; Morihata K; Ito D; Iwai M; Okada K; Usami E; Nakao T; Yoshimura T; Yasuda T
Gan To Kagaku Ryoho; 2010 May; 37(5):829-34. PubMed ID: 20495311
[TBL] [Abstract][Full Text] [Related]
2. [Problems of adjuvant chemotherapy with S-1 for gastric cancer].
Teshima S; Saito T; Endo A; Yunome G; Harada A; Ooshio H; Kodama H; Takeda K; Kikuchi S
Gan To Kagaku Ryoho; 2010 Feb; 37(2):255-8. PubMed ID: 20154480
[TBL] [Abstract][Full Text] [Related]
3. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
[TBL] [Abstract][Full Text] [Related]
4. [Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer].
Matsui K; Nashimoto A; Yabusaki H; Nakagawa S; Nomura T; Takii Y; Tsuchiya Y; Tanaka O
Gan To Kagaku Ryoho; 2009 Jun; 36(6):953-7. PubMed ID: 19542714
[TBL] [Abstract][Full Text] [Related]
5. [Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients].
Kawabata R; Imamura H; Kishimoto T; Hachino Y; Yasui Y; Fujino M; Fujii C; Fukunaga M; Ohzato H; Furukawa H
Gan To Kagaku Ryoho; 2012 Aug; 39(8):1205-8. PubMed ID: 22902443
[TBL] [Abstract][Full Text] [Related]
6. [Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
Nishikawa K; Iwase K; Fujii M; Matsuda C; Shimada K; Hirota M; Kimura T; Wada D; Nasu S; Tanaka Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):595-8. PubMed ID: 19381030
[TBL] [Abstract][Full Text] [Related]
7. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
[TBL] [Abstract][Full Text] [Related]
8. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
[TBL] [Abstract][Full Text] [Related]
10. [Examination of continuity of S-1 adjuvant chemotherapy for gastric cancer patients after gastrectomy].
Kawabata R; Imamura H; Kishimoto T; Anami S; Yasui Y; Fujino M; Fujii C; Sumida R; Furukawa H
Gan To Kagaku Ryoho; 2011 May; 38(5):793-5. PubMed ID: 21566439
[TBL] [Abstract][Full Text] [Related]
11. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
12. [Tolerable evaluation for chemotherapy with S-1 plus cisplatin in elderly patients with advanced and recurrent gastric cancer].
Kimura M; Usami E; Ito D; Iwai M; Okada K; Nakao T; Yoshimura T; Yasuda T
Gan To Kagaku Ryoho; 2012 Aug; 39(8):1209-14. PubMed ID: 22902444
[TBL] [Abstract][Full Text] [Related]
13. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
[TBL] [Abstract][Full Text] [Related]
14. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
Yagi M; Watanabe S; Yoshino S; Hazama S; Suga T; Nakazawa S
Gan To Kagaku Ryoho; 2010 Mar; 37(3):457-62. PubMed ID: 20332683
[TBL] [Abstract][Full Text] [Related]
15. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical care for patients undergoing s-1 plus Cisplatin therapy for unresectable recurrent gastric cancer.
Kimura M; Usami E; Yoshimura T; Yasuda T; Kaneoka Y; Teramachi H; Sugiyama T; Tsuchiya T
J Pharm Pract; 2013 Aug; 26(4):409-14. PubMed ID: 23353075
[TBL] [Abstract][Full Text] [Related]
17. [Induction of liaison-clinical pathway for patients with gastric cancer undergoing adjuvant chemotherapy using S-1 after curative gastrectomy].
Imamura H; Anami S; Watanabe M; Kishimoto T; Miyazaki Y; Kato H; Usui T; Masutani S; Tomotsu K; Furukawa H
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1361-5. PubMed ID: 18701849
[TBL] [Abstract][Full Text] [Related]
18. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer].
Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M
Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients.
Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):335-43. PubMed ID: 17922276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
